Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

193 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Active, not recruiting

Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms

NCT07825207

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
Locations
  • SCDU di Ematologia, AO SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • UO Ematologia con Trapianto, Dipartimento di Medicina di Precisione e Rigenerativa e Area Ionica, AOU Consorziale Policlinico, Università degli Studi Aldo Moro Bari, Italy
  • Istituto di Ematologia L. e A. Seràgnoli, Policlinico di S. Orsola, IRCCS AOU di Bologna Bologna, Italy
  • Comprehensive Cancer Center, Spedali Civili di Brescia Brescia, Italy
View all 26 locations
View Trial Details
Active, not recruiting

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

NCT03816319

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • VCU Massey Comprehensive Cancer Center Richmond, Virginia, United States
View Trial Details
Active, not recruiting

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

NCT05589896

Conditions
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
Locations
  • City of Hope Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University - Winship Cancer Institute Atlanta, Georgia, United States
  • Henry Ford Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, not recruiting

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

NCT01522976

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +24 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 294 locations
View Trial Details
Active, not recruiting

Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm

NCT05600894

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UCI Health Laguna Hills Laguna Hills, California, United States
View all 34 locations
View Trial Details

Related conditions